Selecting the Right Scale
Pearson publishes a wide range of Clinical Outcome Assessments (COAs) used globally in clinical trials. Our portfolio is available for traditional paper-and-pencil administration or can be licensed for digital use on eCOA platforms. With over 80 years of experience in test development, our assessments are built on a foundation of psychometric excellence and validated for use across diverse populations.
Our scales are applicable across various therapeutic areas to evaluate drug efficacy and track changes over time including:
- Anxiety
- Autism
- Adaptive Behavior
- ADHD
- Behavior/Social Wellness
- Cognitive/Neurocognitive Functioning
- Dementia/Alzheimer’s
- Depression
- Executive Functioning
- Language
- Memory
- Mild Cognitive Impairment
- Motor Functioning
- Pediatric Cognitive/Neurocognitive Functioning
- Quality of Life
- Schizophrenia
Considering the Bayley Scales of Infant and Toddler Development™ for your clinical trial?
The Bayley Scales of Infant and Toddler Development are among the most widely used tools in clinical trials assessing neurodevelopmental outcomes. The release of the Bayley™-4 offers sponsors and CROs improved validity, sensitivity, and reliability in their data.
View this flyer to learn more about the key improvements in the Bayley-4 vs. the Bayley™-III.